Mangoceuticals reported a gross margin of 64.31% and a net margin of -2,336.71% for the quarter ended Jun 2026. These financial ratios cover 15 quarters of results from Dec 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||
| Gross Margin | 56.79% | 61.69% | 58.98% | 58.35% | 68.85% | 42.77% | 61.99% | 76.11% | 56.78% | 53.51% | 60.42% | 50.31% | 42.73% | 64.31% | |
| EBT Margin | -2,542.53% | -1,617.16% | -733.99% | -1,050.87% | -1,105.87% | -1,465.60% | -1,499.38% | -1,851.45% | -4,427.47% | -3,221.61% | -9,043.49% | -2,934.90% | -5,014.65% | -1,909.52% | |
| EBIT Margin | -2,540.78% | -1,622.99% | -733.99% | -1,050.87% | -1,105.87% | -1,329.13% | -1,318.21% | -1,594.02% | -4,186.75% | -3,133.98% | -8,953.45% | -389.72% | -4,606.75% | -1,502.45% | |
| EBITDA Margin | -2,540.78% | -1,622.99% | -733.99% | -1,050.87% | -1,105.87% | -1,329.13% | -1,318.21% | -1,594.02% | -4,186.75% | -3,133.98% | -8,953.45% | -389.72% | -4,606.75% | -1,502.45% | |
| Operating Margin | -2,540.78% | -1,622.99% | -733.99% | -1,050.87% | -1,105.87% | -1,329.13% | -1,318.21% | -1,594.02% | -4,186.75% | -3,133.98% | -8,953.45% | -389.72% | -4,606.75% | -1,502.45% | |
| Net Margin | -2,542.53% | -1,617.16% | -733.99% | -1,050.87% | -1,105.87% | -1,465.60% | -1,719.48% | -1,851.22% | -4,696.35% | -3,396.50% | -9,391.80% | -3,246.68% | -5,447.88% | -2,336.71% | |
| FCF Margin | -1,798.83% | -1,260.71% | -697.81% | -694.73% | -462.94% | -966.66% | -874.15% | -1,073.26% | -2,081.11% | -747.40% | -1,473.38% | -1,142.18% | -1,932.31% | -378.88% | |
| Efficiency | |||||||||||||||
| Inventory AverageInventory Avg. | 0.02M | 0.02M | 0.02M | 0.01M | 0.01M | -0.00M | |||||||||
| Assets AverageAssets Avg. | 2.56M | 3.71M | 2.45M | 1.32M | 0.68M | 7.77M | 15.01M | 15.08M | 18.56M | 21.30M | 18.69M | 16.31M | 15.27M | 14.31M | |
| Invested CapitalInvested Cap. | 0.78M | 0.77M | -0.87M | 14.02M | 14.02M | 14.10M | 20.25M | 19.74M | 15.83M | 12.62M | |||||
| Asset Utilization RatioAsset Util. | 0.55 | 1.25 | 0.11 | 0.05 | 0.04 | 0.03 | 0.02 | 0.02 | 0.03 | 0.03 | 0.02 | ||||
| Leverage & Solvency | |||||||||||||||
| Interest Coverage RatioInterest Cover | 334.04 | -242.79 | -99.45 | -18.70 | |||||||||||
| Debt Ratio | 0.17 | 0.29 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | |||||||
| Times Interest Earned | 334.04 | -242.79 | -99.45 | -18.70 | |||||||||||
| Valuation | |||||||||||||||
| Price to EarningsP/E | -5.01 | -13.39 | -7.94 | -1.74 | -2.16 | -3.70 | -3.30 | -2.46 | -1.74 | -2.83 | -3.19 | -2.43 | -1.65 | -4.26 | |
| Price to SalesP/S | 127.43 | 216.58 | 58.25 | 18.26 | 23.93 | 54.29 | 56.66 | 45.50 | 81.94 | 96.24 | 299.58 | 78.98 | 90.03 | 99.58 | |
| Price to BookP/B | 3.36 | 10.19 | 10.54 | 5.76 | -5.35 | 0.64 | 0.55 | 0.34 | 0.44 | 0.84 | 1.60 | 0.49 | 0.45 | 0.55 | |
| Enterprise Value | 9.04M | 27.64M | 13.04M | 3.71M | 5.11M | 8.37M | 7.46M | 4.71M | 8.86M | 16.06M | 24.74M | 5.93M | 5.92M | 6.60M | |
| EV to EBIT | -3.53 | -12.06 | -7.25 | -1.44 | -2.16 | -3.86 | -4.25 | -2.81 | -1.94 | -3.05 | -3.28 | -16.13 | -1.89 | -6.39 | |
| EV to EBITDA | -3.53 | -12.06 | -7.25 | -1.44 | -2.16 | -3.86 | -4.25 | -2.81 | -1.94 | -3.05 | -3.28 | -16.13 | -1.89 | -6.39 | |
| Market Capitalization | 12.84M | 30.59M | 14.28M | 4.46M | 5.12M | 8.86M | 7.56M | 4.79M | 8.96M | 16.18M | 25.24M | 7.45M | 6.11M | 6.85M | |
| Price to FCFP/FCF | -7.08 | -17.18 | -8.35 | -2.63 | -5.17 | -5.62 | -6.48 | -4.24 | -3.94 | -12.88 | -20.33 | -6.92 | -4.66 | -26.28 | |
| EV to FCF | -4.99 | -15.52 | -7.62 | -2.18 | -5.15 | -5.30 | -6.40 | -4.17 | -3.90 | -12.78 | -19.93 | -5.50 | -4.51 | -25.33 | |
| EV to CFO | -5.00 | -15.52 | -7.62 | -2.18 | -5.15 | -5.30 | -6.40 | -4.17 | -3.90 | -12.78 | -19.93 | -5.50 | -4.51 | -25.33 | |
| Return Ratios | |||||||||||||||
| Return on Sales [ROS]ROS | -2,540.78% | -1,622.99% | -733.99% | -1,050.87% | -1,105.87% | -1,329.13% | -1,318.21% | -1,594.02% | -4,186.75% | -3,133.98% | -8,953.45% | -389.72% | -4,606.75% | -1,502.45% | |
| Return on Capital Employed [ROCE]ROCE | -828.98% | 1,683.96% | -139.31% | -65.05% | -58.38% | -59.68% | -67.42% | -106.61% | -115.15% | -112.21% | -93.47% | ||||
| Return on Assets [ROA]ROA | -696.25% | -1,333.96% | -117.46% | -62.12% | -57.74% | -60.23% | -66.69% | -106.08% | -126.56% | -125.79% | -105.54% |